Navigation Links
BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl

arcotic used to treat breakthrough cancer pain. BDSI believes that fentanyl applied with its BEMA(TM) disc technology has the potential to meet the market need for new narcotics and, BDSI believes, will be well suited for breakthrough cancer pain in opioid-tolerant patients.

About BioDelivery Sciences International

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is focused on developing innovative products to treat acute conditions such as pain. The company utilizes its owned and licensed patented drug delivery technologies to develop, partner and commercialize, clinically-significant new products using proven therapeutics. BDSI's pain franchise currently consists of two products in development utilizing the company's patented BEMA(TM) oral adhesive disc technology: BEMA(TM) Fentanyl, a treatment for "breakthrough" cancer pain, and BEMA(TM) LA, a second analgesic with a target indication of the treatment of moderate to severe pain. The company is also working with both its BEMA(TM) technology and its patented Bioral(R) nanocochleate technology on products targeted at other acute treatment opportunities such as insomnia, nausea and vomiting, and infections. The company's headquarters are located in Morrisville, North Carolina and its principal laboratory is located in Newark, New Jersey. For more information please visit www.bdsinternational.com.

Forward-Looking Statements

Note: Except for the historical information contained herein, this press release and the statements of representatives of BioDelivery Sciences International, Inc. (the "Company") related thereto contain or may contain, among other things, certain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements with respect to the Company's plans, objectives, proj
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
(Date:11/29/2009)...Nov. 30 A large proportion of pati...phy (CT) receive unindicated and unnecessary addit...able radiation exposure, according to a study pres...cal Society of North America (RSNA). ,, "It is ... ionizing radiation to ensure that the dosage is a...
(Date:11/29/2009)...Nov. 29 FUJIFILM Medical Systems U...revolutionary flat panel DR cassette, at the 2009 ...l Meeting. Ideal for any clinical environment, FD...de clinicians with Fujifilm,s trademark image qual...a smart way for users to transition to DR without ...
(Date:11/28/2009)..., Nov. 28 Siemens Healthcare rede...m ® (Total imaging matrix) technology and wi...ine. Both technologies are introduced in the new M...GNETOM Skyra* 3T scanners at the 95th Scientific A...iety of North America (RSNA) from November 29 to D...
Breaking Medicine Technology:Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 2Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 3FUJIFILM's DR Cassette Makes World Debut 2Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7ValGenesis Inc the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies Today Announced Support for E 13821 1ValGenesis Inc the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies Today Announced Support for E 13821 2Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration 3A The Building Blocks of Innovation 56116 1Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration 3A The Building Blocks of Innovation 56116 2Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 1Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 2
...OLIS, Oct. 16 In response,to recent media specula...g,application (NDA), Daiichi Sankyo Company, Limit...LY ) reiterated today that they continue to have,d...is application. The,companies have not been notifi...cation (NDA) or of any decision to have an advisor...
...ia, Oct. 16 Cytopia Limited (ASX:,CYT) will prese...tant,scientific meetings this month., Dr Emmanuel...nt a,lecture entitled Targeted JAK2 Inhibitors for...g of the Hematological Society of Australia and Ne...15am AWST., Dr Christopher Burns, Cytopia,s Resea...
Other Medicine Technology:Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application 2Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application 3Cytopia Scientific Presentations on JAK2 Inhibitor Program 2
(Date:11/30/2009)...cades ago, a study revealed that beverage can pull...a switch by U.S. manufacturers to stay-tabs. But a...e Radiological Society of North America (RSNA) fou... , "One of the driving factors leading the chang...eliminate inadvertent swallowing of the pull-tab a...
(Date:11/29/2009)... Moravia,s Nanjing-based Service Delivery Ce..., Brno, Czech Republic (PR... solution provider, is pleased to announce its par...9, to be held in Nanjing, China, on November 30, 2...n-based companies that have established and grown ...
(Date:11/29/2009)...TON, Minn., Nov. 29 Acuo Technolog...management software, data migration tools and serv...d AcuoShare that allows image sharing across the n..., The AcuoShare solution is based on the versati...are. The Acuo AcuoShare enables secure access fro...
(Date:11/29/2009)... Traditional healthcare,s uncertain future a...e alternative care. Affordable Acupuncture Scottsd...PRWEB) November 29, 2009 -- Affordable Acupuncture...009) and has been met with enthusiasm and gratitud... be attributed to two things, need and cost. &quo...
(Date:11/28/2009)...to help lift spirits, recognize signs of depressio... -- For many seniors, the holiday season can trigg... struggle with health issues or worry about money ...iety. , To help overcome the seasonal blues, th...llowing advice: , Get out and socialize or invit...
Breaking Medicine News(10 mins):Health News:Beverage can stay-tabs pose swallowing risk 2Health News:Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China 2Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Seniors May Need Help Overcoming Holiday Blues 2
...tea, or chatting with friends is common, but to do... Welcome to "Lucky Hotel", which is nestled in...ved by waiters, who jump over tombs to serve food ... scared. I feel nice here," said Zakir Bhai, a vis...
...t out at media reports claiming that the she admit... insisted that whatever was written on her Myspace... "It never was on the Myspace blog. Someone made i...d by someone and was spread wrongly. "I di...
...oking rate has shown a decline, thanks to the comp...kick the habit. The statistics in the 2006 report...mparison to 2002 figures. Over the past yea...aimed at prompting more smokers to quit. The new r...
...and only molecular test capable of detecting and m... providing a valuable tool for physicians in manag... Applera Corporation business, announced today tha...g the test to be marketed in the European Union. A...
... researchers has found a new modified drug for Alz...e of clinical trials. Millions of people suf...tions are very limited," said Arun Ghosh, the Purd.... It may be able to prevent and reverse the diseas...
...e University of Pennsylvania School of Medicine ha... eye that could lead to the discovery of the genet...e investigators hope to gain a clearer understandi...measured the types and amounts of proteins in the ...
Other Medicine News:Health News:New York Records Decline in Smoking Rate 2Health News:Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe 2Health News:Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe 3Health News:Modified Drug Therapy for Alzheimers Disease 2Health News:Genetic Cause of Inherited Eye Diseases Identified 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: